1 / 7

2020 Recombinant DNA Technology Market Size, Share and Trend Analysis Report to 2026

Recombinant DNA technology market growth is primarily responsible for the production of recombinant products using rDNA techniques accompanied by CRISPR / Cas9 nuclease, ZFN, and TALEN for fast genome editing with no organism cap.<br><br>In particular, the existence of robust bio-pharmaceutical pipeline, recombinant protein pipeline, to drive the adoption of recombinant DNA technology over the forecast period 2020-2026.<br><br>Further, growth in Genetically Modified (GM) crop hectarage worldwide is a tribute to this technology's popularity in the agriculture and food field.<br><br>Request Free Sample @ https://www.oganalysis.com/sample/216457<br><br>In addition, the use of these technologies has prompted the development of biofuels and bio-pesticides in other non-conventional applications to tackle environmental issues.<br><br>The rDNA technology has revolutionized the medical sector and is impacting clinical practice ever more. Therapeutic agents claim supremacy over the corresponding segments attributable to the emergence of a large number of genetically modified goods for clinical use.<br><br>Browse Recombinant DNA Technology Market, Research Report @ https://www.oganalysis.com/industry-reports/216457/recombinant-dna-technology-market<br><br>Regional analysis of recombinant DNA technology market value<br><br>The North American region holds the major market share attributed to the fact that a significant number of participants in biopharmaceutical manufacturing are headquartered in the U.S. and other developed countries in this region.<br><br>Secondly, regional growth is driven by the presence of effective regulatory bodies to monitor the various ethical and scientific concerns related to the use of technology.<br><br>Additionally, end products which use rDNA techniques in the Pharmaceutical & Biotech segment are highly valued and display significant productivity improvements.<br><br>Further, the emergence of low-cost manufacturing centers in Asian economies, such as China, India and Japan has given considerable attention to translocating the business in this region from international entities.<br><br>However, with the increasing pressure of product improvement and the consequent stress on producers to meet the needs of customers, this technology has slowly emerged as a panacea for tackling these healthcare issues.<br><br>Request for Special Discount on Recombinant DNA Technology Market @ https://www.oganalysis.com/discount/216457<br><br>Collaboration, premeditated studies by key players to trigger the market share<br><br>Advancement in R&D activities, strategic approaches, and collaboration among the key companies are driving the market growth.<br><br>For instance, The Food and Drug Administration (FDA) approved Sevenfact for the treatment and control of bleeding episodes occurring in patients aged u226512 years with hemophilia A or B with inhibitors.<br><br>Further, in 2020 Sanofi collaborated with BARDA. Aslo, researchers at Sanofi leverages its earlier recombinant DNA technology to develop a COVID-19 vaccine.<br><br>In addition, in 2020, AMD approached on their latest RDNA architecture with good mid-range cards.<br><br>Moreover, Mexico is focused on testing its own Covid-19 vaccine created with recombinant DNA technology. As well, Medicago is focused on developing COVID-19 vaccine occurs from recombinant DNA being transferred by a bacterial vector to the nucleus of plant cells.<br><br>Additionally, with use of recombinant DNA technology IU researchers to work on COVID-19 vaccine for modify genetic information of the rotavirus to make 13 proteins.<br><br>Other market players contributing in recombinant DNA technology market include F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen; Amgen Inc., Novartis AG, GenScript, Pfizer Inc, Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Merck & Co., Inc. Biogen, Biocon, GlaxoSmithKline plc, New England Biolabs., Cibus, Monsanto Company, and Horizon Discovery Group PLC among others.<br><br>Related reports<br>u2022 DNA Testing Market<br>u2022 DNA and Gene Chips Market<br>Ambarish Ram<br>OG Analysis<br> 91 73370 13757<br>email us here<br>Visit us on social media:<br>Facebook<br>Twitter<br>LinkedIn

nagaiah
Download Presentation

2020 Recombinant DNA Technology Market Size, Share and Trend Analysis Report to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 6/10/2020 Recombinant DNA Technology Market to emerge with a CAGR of 6.92% (/) Recombinant DNA Technology Market to emerge with a CAGR of 6.92% NEWS PROVIDED BY OG Analysis (http://www.einpresswire.com/newsroom/oganalysis.com/) April 09, 2020, 13:45 GMT SHARE THIS ARTICLE (http://www.facebook.com/sharer.php? u=https%3A%2F%2Fwww.einpresswire.com%2Farticle%2F514169949%2Frecombinant-dna- technology-market-to-emerge-with-a-cagr-of-6- 92&t=Recombinant+DNA+Technology+Market+to+emerge+with+a+CAGR+of+6.92%25) (https://twitter.com/intent/retweet?tweet_id=1248245597187887104) (http://www.linkedin.com/shareArticle? mini=true&url=https%3A%2F%2Fwww.einpresswire.com%2Farticle%2F514169949%2Frecombinant- dna-technology-market-to-emerge-with-a-cagr-of-6- 92&title=Recombinant+DNA+Technology+Market+to+emerge+with+a+CAGR+of+6.92%25) (/article-print/514169949/recombinant-dna-technology-market-to-emerge-with-a-cagr-of-6-92) (https://0e190a550a8c4c8c4b93- fcd009c875a5577fd4fe2f5b7e3bf4eb.ssl.cf2.rackcdn.com/EINPresswire-514169949-recombinant- dna-technology-market-to-emerge-with-a-cagr-of-6-92-1.pdf) https://www.einpresswire.com/article/514169949/recombinant-dna-technology-market-to-emerge-with-a-cagr-of-6-92 1/7

  2. 6/10/2020 Recombinant DNA Technology Market to emerge with a CAGR of 6.92% (/) (https://img.einpresswire.com/large/137289/recombinant-dna-technology- mark.png#483x291) Recombinant DNA Technology Market 2020 Recombinant DNA Technology Market Size, Share and Trend Analysis Report to 2026- Growth Opportunities and Competitive Analysis NEW YORK, UNITED STATES, April 9, 2020 /EINPresswire.com (http://www.einpresswire.com)/ -- Recombinant DNA technology market (https://www.oganalysis.com/industry- reports/216457/recombinant-dna-technology-market) growth is primarily responsible for the production of recombinant products using rDNA techniques accompanied by CRISPR / Cas9 nuclease, ZFN, and TALEN for fast genome editing with no organism cap. In particular, the existence of robust bio-pharmaceutical pipeline, recombinant protein pipeline, to drive the adoption of recombinant DNA technology over the forecast period 2020-2026. Further, growth in Genetically Modi?ed (GM) crop hectarage worldwide is a tribute to this technology's popularity in the agriculture and food ?eld. Request Free Sample @ https://www.oganalysis.com/sample/216457 (https://www.oganalysis.com/sample/216457) In addition, the use of these technologies has prompted the development of biofuels and bio-pesticides in other non-conventional applications to tackle environmental https://www.einpresswire.com/article/514169949/recombinant-dna-technology-market-to-emerge-with-a-cagr-of-6-92 2/7

  3. 6/10/2020 Recombinant DNA Technology Market to emerge with a CAGR of 6.92% issues. (/) The rDNA technology has revolutionized the medical sector and is impacting clinical practice ever more. Therapeutic agents claim supremacy over the corresponding segments attributable to the emergence of a large number of genetically modi?ed goods for clinical use. Browse Recombinant DNA Technology Market, Research Report @ https://www.oganalysis.com/industry-reports/216457/recombinant-dna-technology- market (https://www.oganalysis.com/industry-reports/216457/recombinant-dna- technology-market) Regional analysis of recombinant DNA technology market value The North American region holds the major market share attributed to the fact that a signi?cant number of participants in biopharmaceutical manufacturing are headquartered in the U.S. and other developed countries in this region. Secondly, regional growth is driven by the presence of effective regulatory bodies to monitor the various ethical and scienti?c concerns related to the use of technology. Additionally, end products which use rDNA techniques in the Pharmaceutical & Biotech segment are highly valued and display signi?cant productivity improvements. Further, the emergence of low-cost manufacturing centers in Asian economies, such as China, India and Japan has given considerable attention to translocating the business in this region from international entities. However, with the increasing pressure of product improvement and the consequent stress on producers to meet the needs of customers, this technology has slowly emerged as a panacea for tackling these healthcare issues. Request for Special Discount on Recombinant DNA Technology Market @ https://www.oganalysis.com/discount/216457 (https://www.oganalysis.com/discount/216457) https://www.einpresswire.com/article/514169949/recombinant-dna-technology-market-to-emerge-with-a-cagr-of-6-92 3/7

  4. 6/10/2020 Recombinant DNA Technology Market to emerge with a CAGR of 6.92% Collaboration, premeditated studies by key players to trigger the market share (/) Advancement in R&D activities, strategic approaches, and collaboration among the key companies are driving the market growth. For instance, The Food and Drug Administration (FDA) approved Sevenfact for the treatment and control of bleeding episodes occurring in patients aged ≥12 years with hemophilia A or B with inhibitors. Further, in 2020 Sano? collaborated with BARDA. Aslo, researchers at Sano? leverages its earlier recombinant DNA technology to develop a COVID-19 vaccine. In addition, in 2020, AMD approached on their latest RDNA architecture with good mid- range cards. Moreover, Mexico is focused on testing its own Covid-19 vaccine created with recombinant DNA technology. As well, Medicago is focused on developing COVID-19 vaccine occurs from recombinant DNA being transferred by a bacterial vector to the nucleus of plant cells. Additionally, with use of recombinant DNA technology IU researchers to work on COVID- 19 vaccine for modify genetic information of the rotavirus to make 13 proteins. Other market players contributing in recombinant DNA technology market include F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen; Amgen Inc., Novartis AG, GenScript, P?zer Inc, Novo Nordisk A/S, Eli Lilly and Company, Sano?, Merck & Co., Inc. Biogen, Biocon, GlaxoSmithKline plc, New England Biolabs., Cibus, Monsanto Company, and Horizon Discovery Group PLC among others. Related reports • DNA Testing Market (https://www.oganalysis.com/industry-reports/216210/dna-testing- market) • DNA and Gene Chips Market (https://www.oganalysis.com/industry-reports/216209/dna- gene-chips-market) https://www.einpresswire.com/article/514169949/recombinant-dna-technology-market-to-emerge-with-a-cagr-of-6-92 4/7

  5. 6/10/2020 Recombinant DNA Technology Market to emerge with a CAGR of 6.92% Ambarish Ram OG Analysis (/) +91 73370 13757 email us here (http://www.einpresswire.com/contact_author/514169949) Visit us on social media: Facebook (https://www.facebook.com/OG-Analysis-423357591827764) Twitter (https://twitter.com/OgAnalysis) LinkedIn (https://www.linkedin.com/company/oganalysis/) You just read: Recombinant DNA Technology Market to emerge with a CAGR of 6.92% NEWS PROVIDED BY OG Analysis (http://www.einpresswire.com/newsroom/oganalysis.com/) April 09, 2020, 13:45 GMT SHARE THIS ARTICLE (http://www.facebook.com/sharer.php? u=https%3A%2F%2Fwww.einpresswire.com%2Farticle%2F514169949%2Frecombinant-dna- technology-market-to-emerge-with-a-cagr-of-6- 92&t=Recombinant+DNA+Technology+Market+to+emerge+with+a+CAGR+of+6.92%25) (https://twitter.com/intent/retweet?tweet_id=1248245597187887104) (http://www.linkedin.com/shareArticle? mini=true&url=https%3A%2F%2Fwww.einpresswire.com%2Farticle%2F514169949%2Frecombinant- dna-technology-market-to-emerge-with-a-cagr-of-6- 92&title=Recombinant+DNA+Technology+Market+to+emerge+with+a+CAGR+of+6.92%25) (/article-print/514169949/recombinant-dna-technology-market-to-emerge-with-a-cagr-of-6-92) (https://0e190a550a8c4c8c4b93- fcd009c875a5577fd4fe2f5b7e3bf4eb.ssl.cf2.rackcdn.com/EINPresswire-514169949-recombinant- dna-technology-market-to-emerge-with-a-cagr-of-6-92-1.pdf) https://www.einpresswire.com/article/514169949/recombinant-dna-technology-market-to-emerge-with-a-cagr-of-6-92 5/7

  6. 6/10/2020 Recombinant DNA Technology Market to emerge with a CAGR of 6.92% https://www.einpresswire.com/article/514169949/recombinant-dna-technology-market-to-eme (/) Distribution channels: Banking, Finance & Investment Industry (/channel/banking-?nance- investment), Business & Economy (/channel/business-economy), Companies (/channel/companies), Healthcare & Pharmaceuticals Industry (/channel/healthcare- pharmaceuticals), Retail (/channel/retail) EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to de?ne some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines (/editorial-guidelines) for more information. Contact Company Details Ambarish Ram OG Analysis +91 73370 13757 email us here (/contact-author/514169949) OG Analysis Lakshmi Sai Damam, Hi-Tech City Hyderabad, 500081 India +91 73370 13757 Visit Website (https://www.oganalysis.com) Visit Newsroom (http://www.einpresswire.com/newsroom/oganalysis.com About OG Analysis has been a trusted research partner for 10+ years delivering most reliable analysis, information and innovative solutions. OG Analysis is one of the leading players in market research industry serving 980+ companies across multiple industry verticals. Our core client centric approach comprehends client requirements and provides actionable insights that enable users to take informed decisions. Contact Us: Anil Kumar Phone: +91-7337 01 3757 Email: sales@oganalysis.com () https://www.einpresswire.com/article/514169949/recombinant-dna-technology-market-to-emerge-with-a-cagr-of-6-92 6/7

  7. 6/10/2020 Recombinant DNA Technology Market to emerge with a CAGR of 6.92% (/) More From This Author Intravenous Immunoglobulin (IVIG) Market to grow with a CAGR of 7.2% over the forecast period 2020-2026 (/article/515187388/intravenous-immunoglobulin-ivig-market-to-grow-with-a-cagr-of- 7-2-over-the-forecast-period-2020-2026) Biologics Market to emerge with a robust growth of 10.4% CAGR over 2020-2026 (/article/515097733/biologics-market-to-emerge-with-a-robust-growth-of-10-4-cagr-over-2020- 2026) Animal Health Market to grow with a CAGR of 5.87% during the estimated time period 2020-2026 (/article/515097233/animal-health-market-to-grow-with-a-cagr-of-5-87-during-the-estimated- time-period-2020-2026) View All Stories From This Author (http://www.einpresswire.com/newsroom/oganalysis.com/) PR Distribution Newswires Press Releases Resources Help/Support Contact User Agreement (/user-agreement) Privacy Policy (/privacy-policy) Copyright Policy (/copyright) © 1995-2020 IPD Group, Inc. dba EIN Presswire All Right Reserved. https://www.einpresswire.com/article/514169949/recombinant-dna-technology-market-to-emerge-with-a-cagr-of-6-92 7/7

More Related